arginine has been researched along with medetomidine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bosnjak, ZJ; Coughlan, MG; Kampine, JP; Lee, JG; Schmeling, WT; Warltier, DC | 1 |
Dohi, S; Iida, H; Ishiyama, T; Shimonaka, H; Watanabe, Y | 1 |
Kirsch, JR; McPherson, RW; Traystman, RJ | 1 |
Koehler, RC; McPherson, RW; Traystman, RJ | 1 |
Schlamp, N; Scholz, J; Schulte am Esch, J; Tonner, PH | 1 |
6 other study(ies) available for arginine and medetomidine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Direct coronary and cerebral vascular responses to dexmedetomidine. Significance of endogenous nitric oxide synthesis.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arginine; Cerebral Arteries; Coronary Vessels; Dogs; Female; Imidazoles; In Vitro Techniques; Indomethacin; Male; Medetomidine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Vasoconstriction | 1992 |
Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arginine; Blood Vessels; Brain; Cerebrovascular Circulation; Dogs; Dose-Response Relationship, Drug; Glyburide; Imidazoles; Medetomidine; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxygen Consumption; Pia Mater; Propranolol; Vasoconstrictor Agents; Vasodilator Agents; Yohimbine | 1995 |
Inhibition of nitric oxide synthase does not affect alpha 2-adrenergic-mediated cerebral vasoconstriction.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Brain; Carbon Dioxide; Cerebrovascular Circulation; Dogs; Hemodynamics; Imidazoles; Medetomidine; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxygen; Partial Pressure; Receptors, Adrenergic, alpha-2; Stimulation, Chemical; Vasoconstriction | 1994 |
Hypoxia, alpha 2-adrenergic, and nitric oxide-dependent interactions on canine cerebral blood flow.
Topics: Adrenergic alpha-Agonists; Amino Acid Oxidoreductases; Animals; Arginine; Brain; Carbon Dioxide; Cerebrovascular Circulation; Dogs; Hydrogen-Ion Concentration; Hypoxia; Imidazoles; Medetomidine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Specificity; Oxygen; Oxygen Consumption; Partial Pressure; Receptors, Adrenergic, alpha-2; Regional Blood Flow | 1994 |
Inhibition of nitric oxide metabolism enhances the hypnotic-anesthetic action of the alpha2-adrenoceptor agonist dexmedetomidine in vivo.
Topics: Adrenergic alpha-Agonists; Anesthetics, General; Animals; Arginine; Cyclic AMP; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Hypnotics and Sedatives; Imidazoles; Larva; Medetomidine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Xenopus laevis | 1999 |